SA
GILD icon

SpiderRock Advisors’s Gilead Sciences GILD Stock Holding History

SpiderRock Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$414K Buy
4,937
+662
+15% +$50.5K 0.01% 664
2024
Q2 		$293K Sell
4,275
-12,246
-74% -$817K 0.01% 668
2024
Q1 		$1.21M Buy
+16,521
New +$1.27M 0.03% 367
2017
Q2 		– Hold
0
– – – 809
2017
Q1 		– Hold
0
– – – 24

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SpiderRock Advisors's GILD Position: Q3 2024 in Review

SpiderRock Advisors increased its Gilead Sciences (GILD) stake by 15% in Q3 2024, buying an estimated $50.5K and bringing the position to 4,937 shares worth $414K. The position accounts for 0.01% of the portfolio, ranked #664.

SpiderRock Advisors first reported a position in GILD in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.21M in Q1 2024. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • SpiderRock Advisors held 4,937 shares of Gilead Sciences worth $414K as of Q3 2024.
  • SpiderRock Advisors bought 662 Gilead Sciences shares in Q3 2024, an estimated $50.5K.
  • Gilead Sciences made up 0.01% of SpiderRock Advisors's portfolio in Q3 2024, its #664 holding.
  • SpiderRock Advisors first reported a position in Gilead Sciences in Q1 2024 and has held it in 3 quarters since.
  • SpiderRock Advisors's Gilead Sciences position peaked at $1.21M in Q1 2024.
  • 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.